nanorepertoire: an end-to-end Nextflow pipeline for nanobody repertoire analysis
Camelid heavy-chain antibodies, and particularly their variable domains known as nanobodies or VHHs, combine full antigen-binding capacity with a compact and highly stable scaffold, which makes them attractive for both fundamental immunology and therapeutic development. High-throughput adaptive immune receptor repertoire sequencing (AIRR-seq) allows nanobody repertoires to be profiled at great…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
